Ever since combination antiretroviral therapy (ART) was introduced in 1996, HIV has been transformed from a fatal diagnosis to a chronic and manageable condition for many people. ART made it possible for…
Academic rigor, journalistic flair
Articles on Antiviral drugs
Displaying 41 - 47 of 47 articles
One of the greatest success stories in modern medicine is that HIV is no longer a death sentence, but a chronic, manageable disease that often can be managed with a single tablet a day. Antiretroviral…
A new oral antiviral drug may be a future tool in the global fight against measles, according to a new international study. The research, published today in the journal Science Translational Medicine…
Antiviral drugs are largely ineffective for reducing hospital admissions and complications from influenza, and come with serious side-effects, according to a research review published by the Cochrane Collaboration…
Hepatitis C is a hidden epidemic affecting 170 million people worldwide. Hepatitis C kills nearly 700 Australians every year, mostly from chronic liver failure and liver cancer, and costs over $78.9 million…
Hepatitis C is a blood borne virus and a major cause of liver disease and liver cancer. Around 150m people globally are estimated to suffer from the virus and in the UK, and many developed countries, people…
A new antiviral drug has effectively prevented the spread of influenza in laboratory models. It works by blocking the viruses…
Top contributors
-
Associate Professor of the School of Pharmacy, University of Sydney
-
Professor and Director of Quantitative Biosciences Institute & Senior Investigator at the Gladstone Institutes, University of California, San Francisco
-
Infectious Diseases Physician, St Vincent's Hospital, Sydney; Scientia Professor, Kirby Institute, UNSW Sydney
-
Assistant Professor of Infectious Diseases, University of Virginia
-
Deputy Director, WHO Collaborating Centre for Reference and Research on Influenza
-
Research Associate, University of Bristol
-
Professor of Immunology and Infection, Edinburgh Napier University
-
Deputy Director, Burnet Institute, Adjunct Professor, Monash University, Burnet Institute
-
Director, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital and Consultant Physician, Department of Infectious Diseases, Alfred Hospital and Monash University, The Peter Doherty Institute for Infection and Immunity
-
Associate Professor, The University of Western Australia
-
Professor of Infectious Diseases, Monash University
-
Dean and Hunterdon Professor of Public Health & Health Equity, School of Public Health, Rutgers University
-
Research Fellow, Stellenbosch University
-
Professor in Microbiology and Molecular Biology, UNSW Sydney
-
Senior Research Fellow, School of Medicine, The University of Western Australia
